A detailed history of Shakespeare Wealth Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Shakespeare Wealth Management, Inc. holds 3,649 shares of JNJ stock, worth $567,054. This represents 0.16% of its overall portfolio holdings.

Number of Shares
3,649
Previous 3,561 2.47%
Holding current value
$567,054
Previous $520,000 13.65%
% of portfolio
0.16%
Previous 0.15%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $12,802 - $14,729
88 Added 2.47%
3,649 $591,000
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $6,641 - $7,257
46 Added 1.31%
3,561 $520,000
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $9,468 - $9,927
61 Added 1.77%
3,515 $556,000
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $1,892 - $2,065
-13 Reduced 0.37%
3,454 $541,000
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $25,387 - $28,440
163 Added 4.93%
3,467 $539,000
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $1,852 - $1,993
12 Added 0.36%
3,304 $546,000
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $5,969 - $6,642
37 Added 1.14%
3,292 $538,000
Q2 2022

Aug 09, 2022

BUY
$168.19 - $186.01 $8,409 - $9,300
50 Added 1.56%
3,255 $576,000
Q4 2021

Jan 10, 2022

SELL
$155.93 - $173.01 $18,087 - $20,069
-116 Reduced 3.49%
3,205 $548,000
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $20,833 - $23,151
129 Added 4.04%
3,321 $533,000
Q2 2021

Aug 09, 2021

SELL
$159.48 - $171.07 $198,074 - $212,468
-1,242 Reduced 28.01%
3,192 $553,000
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $154,839 - $169,674
1,103 Added 33.11%
4,434 $660,000
Q1 2020

Apr 01, 2020

SELL
$111.14 - $153.99 $777 - $1,077
-7 Reduced 0.21%
3,331 $437,000
Q4 2019

Feb 10, 2020

SELL
$127.5 - $146.44 $382 - $439
-3 Reduced 0.09%
3,338 $487,000
Q3 2019

Nov 08, 2019

BUY
$126.95 - $142.14 $1,904 - $2,132
15 Added 0.45%
3,341 $432,000
Q2 2019

Aug 12, 2019

SELL
$131.15 - $144.24 $393 - $432
-3 Reduced 0.09%
3,326 $463,000
Q1 2019

May 13, 2019

SELL
$125.72 - $139.79 $377 - $419
-3 Reduced 0.09%
3,329 $465,000
Q4 2018

Feb 04, 2019

SELL
$122.84 - $147.84 $1,474 - $1,774
-12 Reduced 0.36%
3,332 $430,000
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $1,094 - $1,285
9 Added 0.27%
3,344 $462,000
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $597 - $658
-5 Reduced 0.15%
3,335 $405,000
Q1 2018

Aug 14, 2018

BUY
$125.1 - $148.14 $417,834 - $494,787
3,340 New
3,340 $428,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Shakespeare Wealth Management, Inc. Portfolio

Follow Shakespeare Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shakespeare Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Shakespeare Wealth Management, Inc. with notifications on news.